AMR Action Fund
The AMR Action Fund was established in July 2020 by more than 20 leading biopharmaceutical companies as a groundbreaking initiative to commercialize and deliver two to four new antibacterial agents to patients by 2030. The fund is an initiative of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and as an IFPMA member organization, the Pharmaceutical Manufacturers Association of Japan (PMAJ) is contributing to the establishment of the fund and promoting its advocacy.
- AMR Action Fund website
(Japanese website was launched in August 2021)
Announcement of the AMR Action Fund
AMR Action Fund announces its first investment.
AMR Action Fund announces its first investment.
The original text of this announcement is available at https://www.amractionfund.com/resources/amr-action-fund-first-investments.
For the Japanese translation of this joint statement, please click here.
-
*Japanese translation of the joint statement is available atThe Japanese translation of the press release issued by AMR Action Fund on April 4, 2022 has been translated into Japanese and is provided for your reference. The official language is English, and English takes precedence over other languages in terms of content and interpretation.